Sang Yeon Cho1, Ju Seok Kim2,3, Hyuk Soo Eun2,3, Sun Hyung Kang2,3, Eaum Seok Lee2,3, Seok Hyun Kim2,3, Jae Kyu Sung2,3, Byung Seok Lee2,3, Hyun Yong Jeong2,3, Hee Seok Moon4,5. 1. School of Medicine, Chungnam National University, Munwha-ro, 266, Jung-gu, Daejeon, Korea. 2. Department of Internal Medicine, School of Medicine, Chungnam National University, Munwha-ro, 266, Jung-gu, Daejeon, Korea. 3. Division of Gastroenterology, Department of Internal Medicine, Chungnam National University Hospital, Munwha-ro, 282, Jung-gu, Daejeon, 301-721, Korea. 4. Department of Internal Medicine, School of Medicine, Chungnam National University, Munwha-ro, 266, Jung-gu, Daejeon, Korea. mhs1357@cnuh.co.kr. 5. Division of Gastroenterology, Department of Internal Medicine, Chungnam National University Hospital, Munwha-ro, 282, Jung-gu, Daejeon, 301-721, Korea. mhs1357@cnuh.co.kr.
Abstract
BACKGROUND: The NADPH oxidase (NOX) family is overexpressed in many cancers and is associated with cancer cell proliferation and metastasis; however, little is known about the role of the NOX family in colorectal cancer (CRC). AIMS: To identify the expression of the NOX family in CRC and to investigate the relationship between the expression of NOXs with the prognosis of the patients. METHODS: In the TCGA data portal, mRNA expression data were obtained from 41 normal samples and 458 CRC samples to analyze mRNA expression and gene alteration. We compared the survival differences according to the degree of expression of NOX family in CRC patients and performed Gene Set Enrichment Analysis (GSEA). RESULTS: The mRNA expression of NOX1, 3, 4, and DUOX1, 2 was significantly increased in the colorectal adenocarcinoma. Especially, the higher T and N stage, the more NOX4 expression was significantly increased. Survival analyses showed that NOX4 and NOX5 were associated with poor prognosis; however, NOX1 and DUOX2 were significantly associated with better prognosis. In the results of GSEA of CRC patients, the NOX4 gene was significantly associated with Angiogenesis, EMT and notch signaling. CONCLUSIONS: The NOX family is overexpressed in CRC and is associated with the prognosis of the patient. Therefore, NOX family can predict CRC patient survival and the role of the NOX family as a molecular target in the treatment of CRC.
BACKGROUND: The NADPH oxidase (NOX) family is overexpressed in many cancers and is associated with cancer cell proliferation and metastasis; however, little is known about the role of the NOX family in colorectal cancer (CRC). AIMS: To identify the expression of the NOX family in CRC and to investigate the relationship between the expression of NOXs with the prognosis of the patients. METHODS: In the TCGA data portal, mRNA expression data were obtained from 41 normal samples and 458 CRC samples to analyze mRNA expression and gene alteration. We compared the survival differences according to the degree of expression of NOX family in CRC patients and performed Gene Set Enrichment Analysis (GSEA). RESULTS: The mRNA expression of NOX1, 3, 4, and DUOX1, 2 was significantly increased in the colorectal adenocarcinoma. Especially, the higher T and N stage, the more NOX4 expression was significantly increased. Survival analyses showed that NOX4 and NOX5 were associated with poor prognosis; however, NOX1 and DUOX2 were significantly associated with better prognosis. In the results of GSEA of CRC patients, the NOX4 gene was significantly associated with Angiogenesis, EMT and notch signaling. CONCLUSIONS: The NOX family is overexpressed in CRC and is associated with the prognosis of the patient. Therefore, NOX family can predict CRC patient survival and the role of the NOX family as a molecular target in the treatment of CRC.
Entities:
Keywords:
Cancer Genome Atlas data; Colorectal cancer; NOX family; Prognosis
Authors: Kendra D Martyn; Linda M Frederick; Katharina von Loehneysen; Mary C Dinauer; Ulla G Knaus Journal: Cell Signal Date: 2005-05-31 Impact factor: 4.315
Authors: Astrid Lièvre; Jean-Baptiste Bachet; Delphine Le Corre; Valérie Boige; Bruno Landi; Jean-François Emile; Jean-François Côté; Gorana Tomasic; Christophe Penna; Michel Ducreux; Philippe Rougier; Frédérique Penault-Llorca; Pierre Laurent-Puig Journal: Cancer Res Date: 2006-04-15 Impact factor: 12.701
Authors: Sebastian Altenhöfer; Pamela W M Kleikers; Kim A Radermacher; Peter Scheurer; J J Rob Hermans; Paul Schiffers; Heidi Ho; Kirstin Wingler; Harald H H W Schmidt Journal: Cell Mol Life Sci Date: 2012-05-31 Impact factor: 9.261
Authors: Patricia Sancho; Jèssica Mainez; Eva Crosas-Molist; César Roncero; Conrado M Fernández-Rodriguez; Fernando Pinedo; Heidemarie Huber; Robert Eferl; Wolfgang Mikulits; Isabel Fabregat Journal: PLoS One Date: 2012-09-26 Impact factor: 3.240
Authors: Eva Parisi; Anabel Sorolla; Robert Montal; Rita González-Resina; Anna Novell; Antonieta Salud; Maria Alba Sorolla Journal: Cancers (Basel) Date: 2020-11-11 Impact factor: 6.639